Patients should never stop either medication abruptly without medical guidance, as gabapentin requires gradual dose reduction to prevent withdrawal symptoms, and stopping Wegovy may lead to weight regain over time unless lifestyle measures are maintained
For many, shedding is linked to telogen effluviuma stress response that improves as nutrition, routines, and overall balance are restored
So Novo Nordisk went back to the drawing board and created semaglutide
FDA-approved options include Wegovy (semaglutide), Zepbound (tirzepatide), Saxenda (liraglutide), Contrave (naltrexone/bupropion), Qsymia (phentermine/topiramate), and orlistat
Ozempic (semaglutide) is a once-weekly injectable medication also belonging to the GLP-1 receptor agonist class
The pill: The Wegovy pill achieved an average mean weight loss of 17% vs 2.2% placebo over 64 weeks in the OASIS 4 trial. The injection: Wegovy 2.4mg injection was clinically proven to give 14.9% average weight loss over 68 weeks in the Step 1 clinical trials, while Wegovy 7.2mg gave 20.7% average weight loss over 72 weeks in the STEP UP trial. Its worth looking at the clinical trial results before deciding whether switching feels right for you
